3CLD
Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate
Summary for 3CLD
| Entry DOI | 10.2210/pdb3cld/pdb |
| Related | 1m2z |
| Descriptor | Glucocorticoid receptor, Tif2 coactivator motif, (6alpha,11alpha,14beta,16alpha,17alpha)-6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoan drosta-1,4-dien-17-yl furan-2-carboxylate, ... (4 entities in total) |
| Functional Keywords | glucocorticoid receptor, gr, nuclear receptor, alternative initiation, chromatin regulator, disease mutation, dna-binding, lipid-binding, metal-binding, nucleus, phosphoprotein, pseudohermaphroditism, steroid-binding, transcription, transcription regulation, zinc-finger |
| Biological source | Homo sapiens (Human) More |
| Cellular location | Cytoplasm. Isoform Beta: Nucleus: P04150 |
| Total number of polymer chains | 4 |
| Total formula weight | 64006.35 |
| Authors | Shewchuk, L.M.,McLay, I.,Stewart, E.,Biggadike, K.B.,Hassell, A.M.,Bledsoe, R.K. (deposition date: 2008-03-18, release date: 2008-06-24, Last modification date: 2023-08-30) |
| Primary citation | Biggadike, K.,Bledsoe, R.K.,Hassell, A.M.,Kirk, B.E.,McLay, I.M.,Shewchuk, L.M.,Stewart, E.L. X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. J.Med.Chem., 51:3349-3352, 2008 Cited by PubMed Abstract: An X-ray crystal structure is reported for the novel enhanced-affinity glucocorticoid agonist fluticasone furoate (FF) in the ligand binding domain of the glucocorticoid receptor. Comparison of this structure with those of dexamethasone and fluticasone propionate shows the 17 alpha furoate ester to occupy more fully the lipophilic 17 alpha pocket on the receptor, which may account for the enhanced glucocorticoid receptor binding of FF. PubMed: 18522385DOI: 10.1021/jm800279t PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.84 Å) |
Structure validation
Download full validation report






